Seeking Alpha

Supernus Pharmaceuticals (SUPN) dives 16% after pricing a 6M secondary at just $8/share. The...

Supernus Pharmaceuticals (SUPN) dives 16% after pricing a 6M secondary at just $8/share. The stock was trading at $11 late yesterday afternoon. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)